OR WAIT null SECS
© 2023 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
TOKYO, January 19, 2010
-
IntraLinks
, a provider of critical information exchange solutions, announced that Daiichi Sankyo has selected IntraLinks as the company’s information sharing solution. Daiichi Sankyo now joins the world’s top 10 pharmaceutical companies that already leverage IntraLinks’ solution.
Daiichi Sankyo faces many new challenges including developing new innovative pharmaceuticals and ongoing communication with global regulatory bodies. Prior to selecting IntraLinks, Daiichi Sankyo considered a number of information sharing platforms for managing their highly confidential business information in a multi-lingual environment without imposing additional demand on the company’s IT resources. With IntraLinks, Daiichi Sankyo now manages, organizes, tracks and shares critical information both inside and outside the enterprise with 24/7/365 live system support around the world.
“We are extremely pleased to introduce the IntraLinks solution to facilitate secure and speedy information exchange inside and outside the company’s firewall. We plan to use IntraLinks strategically across diverse departments in the near future to raise our standard of operational efficiency,” said Mr. Yasuhiro Ikeda, General Manager, IT Strategy Department of Daiichi Sankyo.
“We are delighted that IntraLinks has been selected by Daiichi Sankyo. As a Software-as-a-Service solution, IntraLinks requires no additional hardware, software, or additional demands on IT resources. Hence our customers can gain tremendous cost efficiencies with a solution that can be implemented in near real-time. We believe the decision by Daiichi Sankyo is yet another testament to the effectiveness of our solution, which has already been widely deployed within the pharmaceutical industry,” said Rob Mullen, EVP of Worldwide Sales for IntraLinks.